デフォルト表紙
市場調査レポート
商品コード
1302727

子宮頸がん診断市場:タイプ別、エンドユーザー別-2023-2030年の世界予測

Cervical Cancer Diagnostic Market by Type, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
子宮頸がん診断市場:タイプ別、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

子宮頸がん診断の世界市場は、2023年にCAGR 10.01%で201億4,000万米ドル、2030年には393億5,000万米ドルという驚異的な規模に達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の子宮頸がん診断市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.子宮頸がん診断の世界市場規模および予測は?

2.予測期間中、世界の子宮頸がん診断市場を形成するCOVID-19の阻害要因と影響は?

3.子宮頸がん診断の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.子宮頸がん診断の世界市場における競争戦略は?

5.子宮頸がん診断の世界市場における技術動向と規制の枠組みは?

6.子宮頸がん診断の世界市場における主要ベンダーの市場シェアは?

7.子宮頸がん診断の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 子宮頸がんの罹患率の増加
      • 非侵襲的処置の採用の増加
      • ヘルスケアインフラを強化する政府の取り組み
    • 抑制要因
      • 新興諸国における高コストと認識の欠如
    • 機会
      • がん診断装置の開発と技術進歩
      • パイプライン診断ツールの規制当局からの承認が継続中
    • 課題
      • 厳しい政府規制
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 子宮頸がん診断市場:タイプ別

  • 子宮頸部生検
  • コルポスコピー
  • 膀胱鏡検査
  • HPV検査
  • パップテスト

第7章 子宮頸がん診断市場:エンドユーザー別

  • がんおよび放射線治療センター
  • 病院
  • 専門クリニックと診断センター

第8章 南北アメリカの子宮頸がん診断市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の子宮頸がん診断市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの子宮頸がん診断市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CERVICAL CANCER DIAGNOSTIC MARKET RESEARCH PROCESS
  • FIGURE 2. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 6. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. CERVICAL CANCER DIAGNOSTIC MARKET DYNAMICS
  • FIGURE 8. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. CERVICAL CANCER DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. CERVICAL CANCER DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CERVICAL CANCER DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CERVICAL BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY COLPOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CYSTOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY HPV TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY PAP TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY CANCER & RADIATION THERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY SPECIALITY CLINICS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM CERVICAL CANCER DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. CERVICAL CANCER DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 101. CERVICAL CANCER DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 102. CERVICAL CANCER DIAGNOSTIC MARKET LICENSE & PRICING
目次
Product Code: MRR-4756B70362FC

The Global Cervical Cancer Diagnostic Market is forecasted to grow significantly, with a projected USD 20.14 billion in 2023 at a CAGR of 10.01% and expected to reach a staggering USD 39.35 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cervical Cancer Diagnostic Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cervical Cancer Diagnostic Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Cervical Biopsies, Colposcopy, Cystoscopy, HPV Testing, and Pap testing. The Pap testing is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Cancer & Radiation Therapy Centers, Hospital, and Speciality Clinics & Diagnostic Centers. The Hospital is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cervical Cancer Diagnostic Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cervical Cancer Diagnostic Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cervical Cancer Diagnostic Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cervical Cancer Diagnostic Market?

4. What is the competitive strategic window for opportunities in the Global Cervical Cancer Diagnostic Market?

5. What are the technology trends and regulatory frameworks in the Global Cervical Cancer Diagnostic Market?

6. What is the market share of the leading vendors in the Global Cervical Cancer Diagnostic Market?

7. What modes and strategic moves are considered suitable for entering the Global Cervical Cancer Diagnostic Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cervical Cancer Diagnostic Market, by Type, 2022 vs 2030
  • 4.3. Cervical Cancer Diagnostic Market, by End-User, 2022 vs 2030
  • 4.4. Cervical Cancer Diagnostic Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cervical cancer cases
      • 5.1.1.2. Rising adoption of non-invasive procedures
      • 5.1.1.3. Government initiatives to increase healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and lack of awareness in developing countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Development and technological advancements in cancer diagnostic devices
      • 5.1.3.2. Ongoing approvals from regulatory agencies of pipeline diagnostic tools
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Cervical Cancer Diagnostic Market, by Type

  • 6.1. Introduction
  • 6.2. Cervical Biopsies
  • 6.3. Colposcopy
  • 6.4. Cystoscopy
  • 6.5. HPV Testing
  • 6.6. Pap testing

7. Cervical Cancer Diagnostic Market, by End-User

  • 7.1. Introduction
  • 7.2. Cancer & Radiation Therapy Centers
  • 7.3. Hospital
  • 7.4. Speciality Clinics & Diagnostic Centers

8. Americas Cervical Cancer Diagnostic Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cervical Cancer Diagnostic Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cervical Cancer Diagnostic Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing